Related Experiment Video
Updated: Jun 1, 2026
04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
Why doesn't the brain lose weight, when obese people diet?
Achim Peters1, Anja Bosy-Westphal, Britta Kubera
1Medical Clinic I, University of Lübeck, Lübeck, Germany. achim.peters@uk-sh.de
Obesity Facts
|May 18, 2011
Summary
Obese women maintain normal brain mass during weight loss due to a protective brain-pull mechanism. This mechanism, involving cerebral insulin suppression, ensures brain energy demands are met, preventing brain shrinkage.
Area of Science:
- Neuroscience
- Obesity Research
- Metabolic Studies
Background:
- Obesity is linked to reduced brain volume.
- Caloric restriction is a common weight-loss strategy.
- Understanding brain's response to weight loss is crucial.
Purpose of the Study:
- To investigate if the brain shrinks after caloric restriction in obese individuals.
- To identify neuroprotective mechanisms during weight loss.
- To assess brain-pull competence and its relation to energy allocation.
Main Methods:
- Interventional study with 52 normal-weight and 42 obese women.
- Assessed organ masses (brain, liver, kidneys), fat, and muscle mass using MRI, plethysmography, and DXA.
- Measured body metabolism via indirect calorimetry and fasting insulin levels.
- Calculated an 'encephalic measure' to quantify brain-body energy allocation.
Main Results:
- Brain mass remained unchanged in obese women before and after weight loss.
- Muscle, fat, liver, and kidney masses decreased significantly post-weight loss.
- Obese women had a lower encephalic measure, which increased after weight loss.
- Insulin concentrations were inversely correlated with the encephalic measure.
Conclusions:
- Brain mass is preserved in obese women during caloric restriction.
- Neuroprotection during weight loss appears mediated by a competent brain-pull mechanism.
- Cerebral insulin suppression may play a key role in protecting brain mass.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...